RANI
Rani Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
2.97 / 10Overall Score
UnderperformInvestment Rating
2.97 / 10Overall Score
UnderperformInvestment Rating
Is RANI a Buy, Sell, or Hold?
- Based on a composite score of 2.97/10, we rate RANI as a Underperform. Our analysis breaks down into 2.42/10 for Fundamentals, 1.84/10 for Technicals, and 3.81/10 for Sentiment, indicating the stock is likely to Face downward pressure.
Technical Analysis of RANI?
Is RANI undervalued or overvalued?
What is the analyst consensus for RANI?
Is RANI a Buy, Sell, or Hold?
- Based on a composite score of 2.97/10, we rate RANI as a Underperform. Our analysis breaks down into 2.42/10 for Fundamentals, 1.84/10 for Technicals, and 3.81/10 for Sentiment, indicating the stock is likely to Face downward pressure.
Is RANI undervalued or overvalued?
Technical Analysis of RANI?
What is the analyst consensus for RANI?
